There is growing concern that a potential coronavirus vaccine won't reach the communities that have been disproportionately affected by the virus — primarily Black, Latinx and Indigenous people. A lack of trust and a shortfall of diversity in early clinical trials present challenges, said Dr. Uché Blackstock, an emergency medicine physician in New York. As more than 100 companies race to find a vaccine, about 41% of non-White Americans say they don't plan to get it when it becomes available — compared to 33% of white Americans, according to a Gallup poll.
|